Literature DB >> 18535177

Amelioration of experimental autoimmune encephalomyelitis in IL-4Ralpha-/- mice implicates compensatory up-regulation of Th2-type cytokines.

Stefanie Gaupp1, Barbara Cannella, Cedric S Raine.   

Abstract

The cytokine receptor interleukin (IL)-4R, expressed by lymphocytes, is well known for its role in immunomodulatory signaling and has also been documented on oligodendrocytes, suggesting involvement in glial cell interactions. In the present study, we investigated the clinical course and pathology of experimental autoimmune encephalomyelitis in mice demonstrating deletion of IL-4R and found a correlation with cytokine expression during acute and chronic disease. Wild-type (WT) littermates served as controls. Although IL-4R(-/-) mice displayed a milder course throughout, they showed comparable pathology to WT in the acute phase. However, during the chronic phase, IL-4R(-/-) mice exhibited extensive remyelination and an apparent increase in oligodendrocytes. Cytokine patterns were examined by immunocytochemistry, fluorescence-activated cell sorting, and enzyme-linked immunosorbent assay and were strongly proinflammatory within the central nervous system during the acute phase in WT mice whereas IL-4R(-/-) animals expressed higher levels of IL-6 and IL-10 that became more pronounced with time. The milder experimental autoimmune encephalomyelitis and enhanced remyelination in IL-4R(-/-) mice appeared to be related to a shift toward a Th-2 pattern involving mainly IL-6 and IL-10. These data suggest that IL-4R exerts a negative regulatory role on oligodendrocytes that when deleted results in enhanced myelin repair.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18535177      PMCID: PMC2438290          DOI: 10.2353/ajpath.2008.071156

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  53 in total

1.  Multiple sclerosis: cytokine receptors on oligodendrocytes predict innate regulation.

Authors:  Barbara Cannella; Cedric S Raine
Journal:  Ann Neurol       Date:  2004-01       Impact factor: 10.422

2.  Single cell analysis reveals that IL-4 receptor/Stat6 signaling is not required for the in vivo or in vitro development of CD4+ lymphocytes with a Th2 cytokine profile.

Authors:  D Jankovic; M C Kullberg; N Noben-Trauth; P Caspar; W E Paul; A Sher
Journal:  J Immunol       Date:  2000-03-15       Impact factor: 5.422

3.  Activation of regulatory cells suppresses experimental allergic encephalomyelitis via secretion of IL-10.

Authors:  S A Stohlman; L Pei; D J Cua; Z Li; D R Hinton
Journal:  J Immunol       Date:  1999-12-01       Impact factor: 5.422

4.  Modulation of susceptibility and resistance to an autoimmune model of multiple sclerosis in prototypically susceptible and resistant strains by neutralization of interleukin-12 and interleukin-4, respectively.

Authors:  C S Constantinescu; B Hilliard; E Ventura; M Wysocka; L Showe; E Lavi; T Fujioka; P Scott; G Trinchieri; A Rostami
Journal:  Clin Immunol       Date:  2001-01       Impact factor: 3.969

5.  Cellular localization and expression patterns of interleukin-10, interleukin-4, and their receptors in multiple sclerosis lesions.

Authors:  Sandra Hulshof; Lisette Montagne; Corline J A De Groot; Paul Van Der Valk
Journal:  Glia       Date:  2002-04-01       Impact factor: 7.452

Review 6.  Interleukin-6 expression and regulation in astrocytes.

Authors:  N J Van Wagoner; E N Benveniste
Journal:  J Neuroimmunol       Date:  1999-12       Impact factor: 3.478

7.  TNF alpha promotes proliferation of oligodendrocyte progenitors and remyelination.

Authors:  H A Arnett; J Mason; M Marino; K Suzuki; G K Matsushima; J P Ting
Journal:  Nat Neurosci       Date:  2001-11       Impact factor: 24.884

8.  Central nervous system gene therapy with interleukin-4 inhibits progression of ongoing relapsing-remitting autoimmune encephalomyelitis in Biozzi AB/H mice.

Authors:  R Furlan; P L Poliani; P C Marconi; A Bergami; F Ruffini; L Adorini; J C Glorioso; G Comi; G Martino
Journal:  Gene Ther       Date:  2001-01       Impact factor: 5.250

9.  Interleukin (IL)-4 is a major regulatory cytokine governing bioactive IL-12 production by mouse and human dendritic cells.

Authors:  H Hochrein; M O'Keeffe; T Luft; S Vandenabeele; R J Grumont; E Maraskovsky; K Shortman
Journal:  J Exp Med       Date:  2000-09-18       Impact factor: 14.307

10.  IL-25 regulates Th17 function in autoimmune inflammation.

Authors:  Melanie A Kleinschek; Alexander M Owyang; Barbara Joyce-Shaikh; Claire L Langrish; Yi Chen; Daniel M Gorman; Wendy M Blumenschein; Terrill McClanahan; Frank Brombacher; Stephen D Hurst; Robert A Kastelein; Daniel J Cua
Journal:  J Exp Med       Date:  2007-01-02       Impact factor: 14.307

View more
  3 in total

1.  Commentary: IL-4 and IL-13 receptors and signaling.

Authors:  Sarah M McCormick; Nicola M Heller
Journal:  Cytokine       Date:  2015-07-14       Impact factor: 3.861

Review 2.  Role of cytokines as mediators and regulators of microglial activity in inflammatory demyelination of the CNS.

Authors:  Tobias D Merson; Michele D Binder; Trevor J Kilpatrick
Journal:  Neuromolecular Med       Date:  2010-03-30       Impact factor: 3.843

3.  The secretome of periodontal ligament stem cells from MS patients protects against EAE.

Authors:  Thangavelu Soundara Rajan; Sabrina Giacoppo; Francesca Diomede; Patrizia Ballerini; Michele Paolantonio; Marco Marchisio; Adriano Piattelli; Placido Bramanti; Emanuela Mazzon; Oriana Trubiani
Journal:  Sci Rep       Date:  2016-12-07       Impact factor: 4.379

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.